Kevin Michael Mullins - 01 Dec 2023 Form 4 Insider Report for LifeStance Health Group, Inc. (LFST)

Role
Chief Development Officer
Signature
By: /s/ Ryan Pardo, Attorney-in-Fact
Issuer symbol
LFST
Transactions as of
01 Dec 2023
Transactions value $
-$741,204
Form type
4
Filing time
04 Dec 2023, 16:05:14
Previous filing
08 Nov 2023
Next filing
04 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFST Common Stock Sale -$741K -113K -2.36% $6.54 4.69M 01 Dec 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.46 to $6.64 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.